Global Pharmaceuticals & Biotech Most Popular Stocks

Mydecine Innovations Group

Market Cap: US$400.2k

A biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions.

Molecular Pharmacology (USA)

Market Cap: US$399.8k

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States.

Asia Green Biotechnology

Market Cap: CA$543.7k

Does not have significant operations.

Hemo Organic

Market Cap: ₹34.4m

Engages in the buying, selling, reselling, importing, exporting, transporting, storing, developing, promoting, supplying, marketing, and dealing of the agricultural products in India and internationally.

DanCann Pharma

Market Cap: DKK 2.5m

A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.

Vaxil Bio

Market Cap: CA$534.2k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

Ecofibre

Market Cap: US$366.6k

Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.

bioXXmed

Market Cap: €312.6k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

Access-Power

Market Cap: US$361.2k

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Molecule Holdings

Market Cap: CA$488.9k

Engages in production and co-packing of cannabis-infused beverages in Canada.

Altamira Therapeutics

Market Cap: US$342.9k

Operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe.

INDVR Brands

Market Cap: €314.1k

Provides personnel and management resources, and infrastructure and equipment for use in production, cultivation, and dispensary operations of licensed cannabis businesses in the United States.

AREV Life Sciences Global

Market Cap: US$317.6k

Operates as an early-stage life science discovery company in Canada.

Digicann Ventures

Market Cap: CA$441.1k

Operates in the cannabis industry.

Xebra Brands

Market Cap: CA$420.7k

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

Jetblack

Market Cap: US$301.1k

Does not have significant operations.

ChitogenX

Market Cap: CA$415.6k

An orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada.

CanaQuest Medical

Market Cap: US$298.9k

Develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils.

Alterola Biotech

Market Cap: US$296.3k

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

Albert Labs International

Market Cap: CA$372.1k

A biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom.

IMAC Holdings

Market Cap: US$265.3k

Through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States.

NanoSphere Health Sciences

Market Cap: CA$359.6k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

Wesana Health Holdings

Market Cap: CA$349.6k

Does not have significant operations.

RegeneRx Biopharmaceuticals

Market Cap: US$242.9k

A biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration.

Panbela Therapeutics

Market Cap: US$242.7k

A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.

WPD Pharmaceuticals

Market Cap: CA$324.8k

Does not have any significant operations.

CNBX Pharmaceuticals

Market Cap: US$226.0k

A clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer.

Synairgen

Market Cap: US$220.5k

Synairgen plc discovers and develops drugs for respiratory diseases.

Beroni Group

Market Cap: US$217.5k

Develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China.

Vincerx Pharma

Market Cap: US$209.4k

Operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States.

NAVCO Pharmaceuticals

Market Cap: CA$285.3k

Develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada.

Greater Cannabis Company

Market Cap: US$202.5k

Engages in the development and commercialization of cannabinoid therapeutics.

Lowell Farms

Market Cap: CA$272.2k

Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.

Tian'an Pharmaceutical

Market Cap: US$196.1k

Develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China.

PAO Group

Market Cap: US$191.0k

Focuses on alternative patient care treatments.

Many Bright Ideas Technologies

Market Cap: CA$258.9k

Does not have significant operations.